ClinicalTrials.Veeva

Menu

Non-invasive Current Stimulation for Restoration of Vision

U

University of Magdeburg

Status and phase

Completed
Phase 2
Phase 1

Conditions

Electrical Stimulation
Stroke

Treatments

Device: repetitive transorbital AC Stimulation
Device: combination of transcranial direct current stimulaton and rtACS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study is to evaluate effects of current stimulation of the brain on vision parameters, vision-related quality of life, and physiological parameters to uncover mechanisms of vision restoration. These include EEG-spectra and coherence measures, and visual evoked potentials. The design of stimulation protocols involves an appropriate sham-stimulation condition and sufficient follow-up periods to test whether the effects are stable. This is the first application of non-invasive current stimulation for vision rehabilitation in stroke-related visual field deficits.

Enrollment

45 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HH due to ischemic or hemorrhagic stroke
  • age between 18 and 75 years
  • lesion age at least 6 months
  • stable visual field defect across baseline measurement (subjects with spontaneous fluctuations and recovery of vision excluded)
  • presence of residual vision and detectable gradual transition between the intact and the absolutely blind part of the visual field according to evaluation of the clinician
  • best corrected visual acuity at least 0.4 (20/50 Snellen) or better

Exclusion criteria

  • known active malignancy
  • eye or central nervous system diseases that interfere with the study (including poorly controlled glaucoma)
  • electric or electronic implants (e.g. heart pacemaker)
  • metal artifacts in the eyes or head (with the exception of dental prosthesis or shunts)
  • expected low compliance (e.g. in case of known psychiatric disease, known drug abuse, and dementing syndromes)
  • epileptic seizure within the last 10 years
  • use of antiepileptic or sedative drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

45 participants in 3 patient groups

rtACS
Experimental group
Description:
repetitive transorbital ACS
Treatment:
Device: combination of transcranial direct current stimulaton and rtACS
Device: repetitive transorbital AC Stimulation
tDCS/rtACS
Experimental group
Description:
Sequential tDCS - tACS
Treatment:
Device: combination of transcranial direct current stimulaton and rtACS
Device: repetitive transorbital AC Stimulation
Sham stimulation
Sham Comparator group
Treatment:
Device: combination of transcranial direct current stimulaton and rtACS
Device: repetitive transorbital AC Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems